ArticlePublic health in practice (Oxford, England)2026
Payment mechanisms to improve prevention spending in health care settings: A policy-focused evidence brief.
Article in Public health in practice (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Early viability assessment of a Business-to-Consumer (B2C) model for digital diabetes screening in Switzerland.BMC health services research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The policy challenge: Decades of evidence indicate that preventative healthcare is both effective and value for money in improving population health long-term. However, healthcare organisations often focus on short-term factors. Leveraging funding mechanisms to promote prevention may facilitate higher implementation of prevention initiatives. The most common funding mechanisms include capitation, Fee-for-service (FFS) and Pay-for-performance (P4P). Here, we explore the policy relevant studies which explore payment incentives for improving long-term population health and under which circumstances these incentives should be encouraged. Key evidence to inform policy: There are six key lessons for policy makers from the evidence base of how healthcare funding mechanisms can be best designed to promote long-term prevention: 1) spending on prevention is highly efficient and its beneficial effects are likely underestimated, 2) well-funded capitation models best incentivise preventative healthcare, 3) variable funding mechanisms, such as FFS and P4P, can be beneficial in increasing quantity focused preventative interventions-those with a uniform and straightforward approach, such as immunisation programs, 4) non-payment to hospitals may be effective in encouraging prevention, 5) Social Impact Bonds may facilitate prevention spending whilst mitigating financial risk away from the public sector, but come with complexity, 6) return on-investment tools can improve spending efficiency, but their impact on decision making is unclear. Further considerations and implications: To most effectively incentivise preventative healthcare, capitation payments should be complemented by more variable funding models for specific preventative services. Alternative payment mechanisms, such as Social Impact Bonds and non-payment may have their place. Integrating equity into decision making shows promise in further improving outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.